Information on the Target
Impress, a Spanish startup founded in 2019 in Barcelona, has revolutionized the field of invisible orthodontics. The company specializes in developing transparent aligners as an alternative to traditional braces, utilizing AI-assisted 3D scanning to customize aligners for each patient. Impress provides a comprehensive orthodontic experience that combines cutting-edge technology with personalized care, allowing for continuous digital monitoring and support by qualified medical professionals.
Since its inception, Impress has rapidly expanded its operations, establishing a network of clinics across more than 130 cities in eight European countries. This impressive growth trajectory is bolstered by the startup’s commitment to innovation and customer service, enabling them to adapt to the evolving needs of patients in the healthcare industry.
Industry Overview in Spain
The orthodontic and dental care market in Spain has experienced significant growth in recent years, driven by rising consumer awareness of dental aesthetics and advancements in orthodontic technology. With an increasing demand for minimally invasive treatments, technologies such as clear aligners are becoming more popular, as they offer a discrete and comfortable alternative to conventional braces.
Spain’s healthcare sector has also seen substantial investments and improvements, particularly in digital healthcare solutions. Telemedicine and remote monitoring technologies are gaining traction, enabling healthcare providers to deliver more personalized patient experiences and reduce in-clinic visits.
The incorporation of AI and digital tools within the orthodontics sector is transforming how treatments are planned and executed, making procedures more efficient and effective. As more patients seek out modern solutions for dental alignment, companies like Impress are well-positioned to capture market share in an increasingly competitive landscape.
Furthermore, the European market is experiencing a notable shift towards digital health solutions, creating opportunities for startups that combine technology with traditional services. The favorable regulatory environment in Spain supports innovation in healthcare, facilitating the growth of both new and existing companies in the market.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
The Rationale Behind the Deal
The recent Series B funding round, which raised $125 million for Impress, underscores investor confidence in the startup’s unique business model and growth potential. By leveraging advanced technology, Impress not only enhances patient experience but also streamlines operations across its clinic network.
This injection of capital will enable Impress to expand its footprint further in Europe and enhance its product offerings, ensuring that it remains competitive in the rapidly evolving orthodontic market. The combination of technological integration and a robust clinic network positions Impress as a leader in the invisible orthodontics segment.
Information about the Investor
Among the key investors in Impress are TA Ventures and a group of early-stage supporters who recognized the startup’s potential from its inception. TA Ventures is a well-regarded investment firm known for backing innovative technology companies that disrupt traditional industries. Their involvement in this funding round suggests a strong belief in Impress’s growth trajectory and strategic vision.
The presence of experienced investors not only provides financial support but also offers strategic guidance and industry connections, which can prove invaluable as Impress continues to scale its operations and refine its offerings to better serve patients.
View of Dealert
The valuation of Impress following its Series B funding is indicative of a strong market perception and recognition of its growth potential. Given the startup's innovative approach and rapid expansion, this investment could be a prudent choice for investors looking to enter the healthcare technology space, particularly in orthodontics. The combination of an experienced leadership team and advanced technology positions Impress favorably for future growth.
However, investors should remain aware of the challenges associated with scaling healthcare solutions that combine both hardware and software components. The integration of these elements requires careful management to ensure smooth operations and patient satisfaction. Nonetheless, the current momentum and robust business model suggest that Impress could yield significant returns as it navigates these complexities.
In conclusion, while the orthodontic market presents various challenges, the demand for tech-driven solutions is growing. Impress’s unique offering and its commitment to adaptive patient care are solid foundations for ongoing success. Therefore, this investment opportunity appears to be worthwhile, given the anticipated growth and increasing consumer demand for innovative orthodontic solutions.
Similar Deals
Asabys, Buenavista, GoHub Ventures, UI Investissement, Amadeus Capital Partners, APEX Ventures, Partech, Adara Ventures, Leadwind, individual investors → Quibim
2025
TVM Capital Healthcare → Baraya Extended Care
2025
EQT Life Sciences, Sanofi Ventures, Roche Venture Fund → SpliceBio
2025
Miura Partners → Centro Psicosanitario Galiani and Orientak
2025
Impress
invested in
Impress
in 2023
in a Series B deal
Disclosed details
Transaction Size: $125M